Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An inherited connective tissue disorder that is caused by defects in a protein called collagen. Common symptoms include severe joint hypermobility ; congenital hip dislocation; fragile, hyperextensible skin; hypotonia ; and kyphoscoliosis (kyphosis and scoliosis). EDS, arthrochalasia type is caused by changes (mutations) in the COL1A1 gene or the COL1A2 gene and is inherited in an autosomal dominant manner. Treatment and management is focused on preventing serious complications and relieving associated signs and symptoms.
No HPO annotations are available for this condition.
Age of onset: at birth.
Classic Ehlers-Danlos syndrome (cEDS) is a heritable connective tissue disorder characterized by skin hyperextensibility, abnormal wound healing, and generalized joint hypermobility. Skin. Skin is hyperextensible; it extends easily and snaps back after release (unlike lax, redundant skin, as in cutis laxa). The skin is soft, velvety, or doughy to the touch. The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Skin fragility may cause dehiscence of sutured incisions in skin or mucosa. Wound healing is poor, and stretching, thinning, and pigmentation of scars is characteristic.
Source: GeneReviews — "Classic Ehlers-Danlos Syndrome"
There are no consensus clinical diagnostic criteria for classic Ehlers-Danlos syndrome (cEDS); diagnosis requires molecular testing. Suggestive Findings Classic EDS should be suspected in a proband with either of the following: • skin hyperextensibility and atrophic scarring OR • generalized joint hypermobility (GJH) and/or ≥3 Major criteria • Skin hyperextensibility is measured by pinching and lifting the cutaneous and subcutaneous layers of the skin on the volar surface at the middle of the nondominant forearm as described by . Skin is hyperextensible if it can be stretched over a standardized cutoff in three of the following areas: 1.5 cm for the distal part of the forearms and the dorsum of the hands; 3 cm for neck, elbows, and knees. • Atrophic scarring (See .)
• GJH depends on an individual's age, sex, and family and ethnic background. Joint hypermobility in cEDS is usually general, affecting both large and small joints, and is usually noted when a child starts to walk. It should be assessed using the Beighton scale, the most widely accepted grading system for the objective semiquantification of joint hypermobility . A Beighton score of ≥5 is considered positive for the presence of GJH.Table 1. Beighton Criteria for Joint HypermobilityJoint/Finding. Negative. Unilateral. Bilateral. Passive dorsiflexion of the 5th finger 90. 0. 1. 2. Passive flexion of thumbs to the forearm. 0. 1. 2. Hyperextension of the elbows beyond 10. 0. 1. 2. Hyperextension of the knees beyond 10. 0. 1. 2. Forward flexion of the trunk with knees fully extended and palms resting on the floor. 0. 1 Since laxity decreases with age, individuals with a Beighton score of 5 may be considered positive based on historical observations.. —
Source: GeneReviews — "Classic Ehlers-Danlos Syndrome"
Other forms of Ehlers-Danlos syndrome (EDS) should be considered in individuals with easy bruising, joint hypermobility, and/or chronic joint dislocation. Clinical overlap with classic EDS (cEDS) is seen with all other forms of EDS, in particular with hypermobile EDS (hEDS) and the EDS types listed in . Hypermobile EDS is generally considered the least severe type of EDS, although significant complications, primarily musculoskeletal, can occur. Similar to cEDS, generalized joint hypermobility, mild atrophic scarring, mild skin hyperextensibility, and soft, velvety skin are seen in hEDS. Unlike cEDS, hEDS is not associated with truly papyraceous and/or hemosiderotic scars. The diagnosis of hEDS is based entirely on clinical evaluation and family history. The gene(s) in which pathogenic variants cause hEDS are unknown. Table 4. Ehlers-Danlos Syndrome-Related Genes of Interest in the Differential Diagnosis of Classic Ehlers-Danlos Syndrome
Gene(s) | Disorder | MOI | Clinical Features of Disorder |
|---|---|---|---|
ADAMTS2 |
No approved treatments are currently available for Ehlers-Danlos syndrome, arthrochalasia type. The disease remains an area of unmet medical need.
For a detailed review of complications and management of classic Ehlers-Danlos syndrome (cEDS), see . Evaluations Following Initial Diagnosis To establish the extent of disease in an individual diagnosed with cEDS, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 5. Classic Ehlers-Danlos Syndrome: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment |
|---|---|---|
Skin | Clinical exam of skin w/assessment of skin hyperextensibility, atrophic scars bruises, other manifestations of cEDS | — |
Joints | Eval of joint mobility w/Beighton score | — |
Neurologic | Eval for hypotonia motor development in infants children | Hematologic |
Cardiovascular | Echocardiogram w/aortic diameter measurement | — |
Genetic counseling | By genetics professionals1 | To inform affected persons their families re nature, MOI, implications of cEDS to facilitate medical personal decision making cEDS = classic Ehlers-Danlos syndrome; MOI = mode of inheritance; aPTT = activated partial thromboplastin time; PT = prothrombin time 1. |
Source: GeneReviews — "Classic Ehlers-Danlos Syndrome"
Sports with heavy joint strain should be avoided (contact sports, fighting sports, football, running).
Source: GeneReviews — "Classic Ehlers-Danlos Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "Classic Ehlers-Danlos Syndrome"
View trials for Ehlers-Danlos syndrome, arthrochalasia type
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended.
Table 7.
Classic Ehlers-Danlos Syndrome: Recommended Surveillance
System/Concern | Evaluation | Frequency
Skin | Assessment for skin fragility | At each visit or as needed
| Assessment for joint instability, occupational physical therapy needs, mobility issues, pain
| Eval for hypotonia motor development | At each visit in infants children
| Assessment for easy bruising /or prolonged bleeding | At each visit
Eval of clotting factors (platelet count, aPTT, PT, thrombin time) | If severe easy bruising is present
| Echocardiogram | In those w/normal initial echocardiogram:
Children: frequency of follow up per pediatric cardiologist
Adults: no follow-up echocardiogram necessary
In those w/abnormal echocardiogram (aortic dilatation, mitral valve prolapse): annually
aPTT = activated partial thromboplastin time; PT = prothrombin time
Source: GeneReviews — "Classic Ehlers-Danlos Syndrome"
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for Ehlers-Danlos syndrome, arthrochalasia type.
43 publications have been identified in PubMed for Ehlers-Danlos syndrome, arthrochalasia type. Research spans Clinical Trial Publication (23%), Basic Science / Preclinical (23%), and Epidemiology / Natural History (23%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 10 | 23% |
Laboratory research | 10 | 23% |
Disease patterns and progression | 10 | 23% |
Patient case studies | 9 | 21% |
Other research | 2 | 5% |
Research summaries | 2 | 5% |
Wahman JM (2026). [PMID: 41734363](https://pubmed.ncbi.nlm.nih.gov/41734363/). *JMIR Form Res*. [Other]
Khamissi FZ (2026). [PMID: 41173024](https://pubmed.ncbi.nlm.nih.gov/41173024/). *Am J Perinatol*. [Case Report / Case Series]
Davidson L (2026). [PMID: 41489686](https://pubmed.ncbi.nlm.nih.gov/41489686/). *Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery*. [Case Report / Case Series]
Willie-Permor D (2026). [PMID: 41643850](https://pubmed.ncbi.nlm.nih.gov/41643850/). *Annals of vascular surgery*. [Clinical Trial Publication]
Elhance A (2026). [PMID: 41616879](https://pubmed.ncbi.nlm.nih.gov/41616879/). *Journal of vascular surgery*. [Clinical Trial Publication]
Arai W (2026). [PMID: 41492809](https://pubmed.ncbi.nlm.nih.gov/41492809/). *Pathol Int*. [Case Report / Case Series]
Albarian SB (2026). [PMID: 42235880](https://pubmed.ncbi.nlm.nih.gov/42235880/). *J Shoulder Elbow Surg*. [Case Report / Case Series]
van den Bersselaar LM (2026). [PMID: 40104886](https://pubmed.ncbi.nlm.nih.gov/40104886/). *BJOG : an international journal of obstetrics and gynaecology*. [Basic Science / Preclinical]
Rozen TD (2026). [PMID: 41745718](https://pubmed.ncbi.nlm.nih.gov/41745718/). *Neurology international*. [Epidemiology / Natural History]
Calderon-Martinez E (2025). [PMID: 40533124](https://pubmed.ncbi.nlm.nih.gov/40533124/). *Journal of the American College of Cardiology*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:59 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Ehlers-Danlos syndrome, arthrochalasia type
Dermatosparaxis EDS (OMIM 225410)
AR |
Atrophic scarring; Easy bruising; GJH; Skin hyperextensibility; Soft, doughy skin |
AEBP1 | Classic-like EDS type 2 (OMIM 618000) | AR | Atrophic scarring; Easy bruising; GJH; Skin hyperextensibility |
COL1A2 | Arthrochalasia EDS (OMIM 130060, 617821) | AD | Atrophic scarring; Easy bruising; GJH; Skin hyperextensibility |
COL1A2 | Cardiac valvular EDS (OMIM 225320) | AR | Atrophic scarring; Easy bruising; (Generalized) joint hypermobility; Skin hyperextensibility |
Severe progressive cardiac valvular problems COL3A11 | Vascular EDS1 | AD | Atrophic scarring; Easy bruising; GJH; Skin hyperextensibility; Doughy skin |
FKBP14-related kyphoscoliotic EDS | AR | Easy bruising; GJH; Skin hyperextensibility | Congenital muscle hypotonia; Muscle atrophy; Congenital hearing impairment PLOD1 |
PLOD1-related kyphoscoliotic EDS | AR | Atrophic scarring; Easy bruising; GJH; Skin hyperextensibility | Congenital muscle hypotonia TNXB |
TNXB-related classic-like EDS | AR | Easy bruising; GJH; Skin hyperextensibilityy; Velvety skin AD = autosomal dominant; AR = autosomal recessive; cEDS = classic Ehlers-Danlos syndrome; EDS = Ehlers-Danlos syndrome; GJH = generalized joint hypermobility; MOI = mode of inheritance 1. | — |
Source: GeneReviews — "Classic Ehlers-Danlos Syndrome"
Classic Ehlers-Danlos Syndrome: Treatment of Manifestations Manifestation/Concern | Treatment | Considerations/Other Skin |